Brief: MaxCyte Q1 Revenue USD 8.2 Million Vs. IBES Estimate USD 9.06 Million
07/05/2025 21:05
May 07 (Reuters) - MaxCyte Q1 operating expenses USD 21.2 million. Q1 cash & investments USD 174.7 million Q1 gross profit USD 8.9 million Q1 adjusted EBITDA USD -11.2 million Q1 net income USD -10.3 million
Recent news on MaxCyte
See all newsMaxCyte Q1 revenue falls
Brief: Maxcyte Appoints Parmeet Ahuja As Chief Financial Officer
Brief: Maxcyte Announces Preliminary Unaudited Fourth Quarter And Full Year 2025 Financial Results
MaxCyte Q3 revenue falls 16% hurt by lower sales in instruments
Brief: MaxCyte Announces Planned CFO Transition In 2026